热门资讯> 正文
Alumis报告第二季度业绩
2024-08-15 01:59
- Alumis press release (NASDAQ:ALMS): Q2 As of June 30, 2024, Alumis had cash and cash equivalents and marketable securities of $209.5 million, which, together with aggregate net proceeds from the closing of its IPO and concurrent private placement of $233.2 million, is expected to fund operations into 2026.
- Net loss was $56.5 million for the quarter ended June 30, 2024, compared to $36.3 million for the same period in 2023.
More on Alumis
- Alumis' $100 Million IPO: Promising Psoriasis Treatment Results
- Alumis prices IPO at $16 per share
- Immunology drug developer Alumis files for $100M IPO
- Historical earnings data for Alumis
- Financial information for Alumis
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。